Investment Insights for Profits with Purpose

Ecolab is the world's largest water conservation company — and most investors have never heard of it. In 2024 alone, its technology helped customers save 226 billion gallons of water while a blockbuster acquisition has planted it at the heart of the AI data center cooling boom. With a Ziggma Score of 77, 21% analyst upside, and an ACA Ethos Impact Score of 70, ECL is one of the most compelling Good Stocks in the series to date.

Insulet ($PODD) is down nearly 60% from its 52-week high—yet revenue just surged 34%. Wall Street smells a massive disconnect. With 24 "Strong Buy" ratings and a 64% implied upside, this isn't a failing business; it’s a high-growth recovery play.

Managing investments across multiple brokers makes it nearly impossible to see your portfolio clearly. Account aggregation solves this by connecting all your accounts into a single, unified view — powered by API-based providers like Plaid and Snaptrade that use OAuth, read-only access, and bank-grade encryption. The result is full portfolio visibility without ever sharing your login credentials.

The data’s getting hard to ignore — companies solving real-world problems are also delivering real-world profits. A joint study by Schroders and Oxford Saïd Business School finds up to 9% annual alpha through impact investing. This post breaks down what the numbers are really saying about making money and making impact.

Rivian posted its first full year of positive gross profit, its $45,000 R2 SUV is now rolling off the line, and a $5.8 billion Volkswagen joint venture validates the technology. The R1T already cuts full lifecycle carbon 34% below the tailpipe emissions of a comparable gas pickup, and the Climate Action score sits at 72/100. For impact-oriented investors with patience and conviction, RIVN's inflection is quietly underway.

Most investors don't realize they're already impact investors — their portfolios are backing companies whether they chose them or not. This post breaks down the $87 trillion case for public-market impact investing, debunks the sacrifice myth, and lays out six concrete strategies anyone can use to make their portfolio deliberate.

Edwards Lifesciences helped transform heart care through minimally invasive valve replacement technologies. After years of market leadership, the stock now trades far below historical valuation levels as investors worry about slowing growth. Yet Edwards still combines elite profitability, a powerful moat, and promising new growth drivers in structural heart disease. We analyze what’s in store for one of healthcare’s highest-quality compounders.

Visa sits at the center of the global shift toward digital commerce, AI-driven transactions, and the decline of cash. Despite strong growth prospects and rising profitability, the stock currently trades below its historical valuation averages. Massive share buybacks and extraordinary financial strength continue supporting long-term shareholder returns. Solid climate metrics and renewable energy commitments make Visa a compelling GoodStock.

AI is creating a global electricity boom, and GE Vernova sits at the center of it. The company dominates critical power infrastructure markets spanning gas turbines, grid equipment, and renewables. With a massive backlog, accelerating earnings growth, and strong climate metrics, GEV looks increasingly strategic.

First Solar just confirmed strong growth and reaffirmed guidance, but the real story is evolving. AI-driven electricity demand is accelerating solar build-outs across the US. With a ~48GW backlog and attractive valuation, FSLR offers rare visibility and upside.

Many investors want portfolios that deliver strong long-term returns while remaining aligned with their values. This case study explores how socially conscious investors use Ziggma’s Portfolio Checkup and Optimizer to improve diversification, portfolio quality, risk management, and real-world impact alignment. Rather than relying on ESG labels alone, investors gain deeper visibility into what their portfolio actually supports. The result is a more intentional, resilient, and better-understood portfolio.

Climate change is one of the largest capital allocation challenges in modern history. Trillions of dollars will need to flow into energy, infrastructure, electrification, and climate solutions over the coming decades, yet the world remains far behind. In this post on climate impact investing we explain why the future of the climate transition may depend as much on where investors allocate capital as on government policy itself.

ESG and impact investing are not the same thing — and the difference matters more than most investors realize. One measures risk. The other measures results. Using a striking real-world example, this article unpacks why high ESG scores don't signal genuine impact, and what a portfolio built around real-world outcomes actually looks like.

A reverse stock split may make a struggling stock look more expensive — but it doesn’t fix the underlying business. While a few companies recover after one, most use it as a last resort, making careful analysis essential before seeing opportunity where there may only be risk.

TJX built its success by solving one of fashion’s biggest problems: excess inventory. Up to 30% of clothing goes unsold, creating massive inefficiency. TJX turns that waste into value while delivering steady growth and strong returns.

The market prices Accenture (ACN 🔎) at a record low valuation. At the same time, bookings are at record highs. Is this a major opportunity or a value trap?

A negative P/E ratio can look like an instant red flag — but is it really a reason to walk away? Understanding why a company has negative earnings can reveal whether you’re seeing a warning sign or a misunderstood opportunity hiding behind the numbers.

Agilent Technologies is a hidden force behind modern healthcare, diagnostics, and food safety. After a period of slowed growth, earnings are set to re-accelerate with projected 30.6% growth next year. At the same time, valuation has reset to more attractive levels, creating a compelling entry point. This is a high-quality compounder with real-world impact and renewed upside.